A patient with type 2n von Willebrand disease is heterozygous for a new mutation: Gly22Glu. Demonstration of a defective expression of the second ailele by the use of monoclonal antibodies

Blood

Volumn 89, Issue 9, 1997, Pages 3263-3269

  Gu, J ^b   Jorieux, S ^b   Lavergne, J M ^b   Ruan, C ^b   Mazurier, C ^b   Meyer, D ^a  

^a BICÊTRE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; MONOCLONAL ANTIBODY; VON WILLEBRAND FACTOR;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PHENOTYPE; PRIORITY JOURNAL; VON WILLEBRAND DISEASE;

EID: 0030905830     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.9.3263     Document Type: Article

References (29)

1. Meyer D, Girma JP: von Willebrand factor: Structure and function. Thromb Haemost 70:99, 1993
2. Mancuso DJ, Tuley EA, Westfield LA, Worrall NK, Shelton-Inloes BB, Sorace JM, Alevy YG, Sadler JE: Structure of the gene for human von Willebrand factor. J Biol Chem 264:19514, 1989
3. Titani K, Kumar S, Takio K, Ericsson LH, Wade RD, Ashida K, Walsh KA, Chopek MW, Sadler JE, Fujikawa K: Amino acid sequence of human von Willebrand factor. Biochemistry 25:3171, 1986
4. Shelton-Inloes BB, Titani K, Sadler JE: cDNA sequence for human von Willebrand factor reveals five types of repeated domains and five possible protein sequence polymorphisms. Biochemistry 25:3164, 1986
5. Foster PA, Fulcher CA, Marti T, Titani K, Zimmerman TS: A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. J Biol Chem 262:8443, 1987
6. Takahashi Y, Kalafatis M, Girma JP, Sewerin K, Andersson LO, Meyer D: Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factor. Blood 70:1679, 1987
7. Sadler JE: A revised classification of von Willebrand disease. Thromb Haemost 71:520, 1994
8. Nishino M, Girma JP, Rothschild C, Fressinaud E, Meyer D: New variant of von Willebrand disease with defective binding to factor VIII. Blood 74:1591, 1989
9. Mazurier C, Diéval J, Jorieux S, Delobel J, Goudemand M: A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/ FVIII interaction. Blood 75:20, 1990
10. Mazurier C, Meyer D: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease. Results of an international survey. Thromb Haemost 76:270, 1996
11. Kroner PA, Friedman KD, Fahs SA, Scott JP, Montgomery RR : Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease. J Biol Chem 266:19146, 1991
12. Cacheris PM, Nichols WC, Ginsburg D: Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor/factor VIII interaction. J Biol Chem 266:13499, 1991
13. Peerlinck K, Eikenboom JCJ, Ploos Van Amstel HK, Sangtawesin W, Arnout J, Reitsma PH, Vermylen J, Briët E: A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg 854 by Gln in the putative factor VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele. Br J Haematol 80:358, 1992
14. Siguret V, Lavergne JM, Chérel G, Boyer-Neumann C, Ribba AS, Bahnak BR, Meyer D, Piétu G: A novel case of compound heterozygosity with "Normandy"/type I von Willebrand disease (vWD). Direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD. Human Genet 93:95, 1994
15. Kroner PA, Foster PA, Fahs SA, Montgomery RR: The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg 19 and His 54 in mature von Willebrand factor. Blood 87:1013, 1996
16. Mazurier C, Gaucher C, Jorieux S, Parquet-Gernez A, Goudemand M: Evidence for a von Willebrand factor defect in factor VIII binding in three members of a family previously misdiagnosed mild hemophilia A and hemophilia A carriers: Consequences for therapy and genetic counselling. Br J Haematol 76:372, 1990
17. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487, 1988
18. Ribba AS, Lavergne JM, Bahnak BR, Derlon A, Piétu G, Meyer D: Duplication of a methionine within the glycoprotein Ib binding domain of von Willebrand factor detected by denaturing gradient gel electrophoresis in a patient with type IIB von Willebrand disease. Blood 78:1738, 1991
19. Atree O, Vidaud D, Vidaud M, Amselem S, Lavergne JM, Goossens M: Mutation in the catalytic domain of human coagulation factor IX: Rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behaviour. Genomics 4:266, 1989
20. Hubert L, Gaucher C, de Romeuf C, Horellou MH, Vink T, Mazurier C: Leu 69 → Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease. Blood 83:1542, 1994
21. Bonthron D, Orr EC, Mitsock LM, Ginsburg D, Handin RI, Orkin SH: Nucleotide sequence of pre-pro-von Willebrand factor cDNA. Nucleic Acids Res 14:7215, 1986
22. Adams GA, Rose JK: Incorporation of a changed amino acid into the membrane-spanning domain blocks cell surface transport but not membrane anchoring of a viral glycoprotein. Mol Cell Biol 5:555, 1986
23. Mazurier C, Parquet-Gernez A, Goudemand M: Dosage de l'antigène lié au facteur VIII par la technique ELISA. Intérêt dans l'étude de la maladie de Willebrand. Pathologie Biologie 25:18, 1977
24. Piétu G, Ribba AS, Chérel G, Siguret V, Obert B, Rouault C, Ginsburg D, Meyer D: Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries. Thromb Haemost 71:788, 1994
25. Jorieux S, Gaucher C, Piétu G, Chérel G, Meyer D, Mazurier C: Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: Interest for the localization of the factor VIII binding domain. Br J Haematol 87:113, 1994
26. Mazurier C: von Willebrand disease masquerading as haemophilia A. Thromb Haemost 67:391, 1992
27. Gaucher C, Jorieux S, Mercier B, Oufkir D, Mazurier C: The "Normandy" variant of von Willebrand disease: Characterization of a point mutation in the von Willebrand factor gene. Blood 77:1937, 1991
28. Tuley EA, Gaucher C, Jorieux S, Worrall NK, Sadler JE, Mazurier C : Expression of von Willebrand factor "Normandy": An autosomal mutation that mimics hemophilia A. Proc Natl Acad Sci USA 88:6377, 1991
29. Schneppenheim R, Budde U, Krey S, Drewke E, Bergmann F, Lechler E, Oldenburg J, Schwaab R: Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1. Thromb Haemost 76:588, 1996